InVivo Therapeutics Hldgs Corp (fka NVIVQ)

[rru2s]

Technically this is way, way oversold. Also, if only one of the various events is triggered, we are off to the races being this oversold. Such news could be corporate governance material changes (such as appointing new audit team members - tells us uplisting is getting closer), actual uplisting itself (need I say more?), announcement of the enrollment of the first scaffold patient (probably a game changer there), and announcement of a half-decent schedule for hydrogel (will make a small difference but not big difference until FDA application is filed).